TipRanks
Standard BioTools (CH:FLB)
:FLB
Switzerland Market
FLB
Standard BioTools
RESEARCH TOOLSreports

Standard BioTools (FLB) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

FLB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Standard
BioTools
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FLB Stock 12 Month Forecast

There Are No Analyst Ratings for CH:FLB In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FLB Financial Forecast

FLB Earnings Forecast

Next quarter’s earnings estimate for FLB is -CHF0.02 with a range of -CHF0.02 to -CHF0.02. The previous quarter’s EPS was -CHF0.06. FLB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year FLB has Performed in-line its overall industry.
Next quarter’s earnings estimate for FLB is -CHF0.02 with a range of -CHF0.02 to -CHF0.02. The previous quarter’s EPS was -CHF0.06. FLB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year FLB has Performed in-line its overall industry.

FLB Sales Forecast

Next quarter’s sales forecast for FLB is CHF15.20M with a range of CHF15.20M to CHF15.20M. The previous quarter’s sales results were CHF16.26M. FLB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year FLB has Performed in-line its overall industry.
Next quarter’s sales forecast for FLB is CHF15.20M with a range of CHF15.20M to CHF15.20M. The previous quarter’s sales results were CHF16.26M. FLB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year FLB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on CH:FLB
Kyle Boucher
TD Cowen
TD Cowen
CHF1.12
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Standard BioTools (NASDAQ: LAB) and Fortrea Holdings Inc. (NASDAQ: FTRE)
KeyBanc Analyst forecast on CH:FLB
Paul Knight
KeyBanc
KeyBanc
―
Hold
―
Reiterated
02/25/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Globus Medical (NYSE: GMED), Standard BioTools (NASDAQ: LAB) and Addus Homecare (NASDAQ: ADUS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on CH:FLB
Kyle Boucher
TD Cowen
TD Cowen
CHF1.12
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Standard BioTools (NASDAQ: LAB) and Fortrea Holdings Inc. (NASDAQ: FTRE)
KeyBanc Analyst forecast on CH:FLB
Paul Knight
KeyBanc
KeyBanc
―
Hold
―
Reiterated
02/25/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Globus Medical (NYSE: GMED), Standard BioTools (NASDAQ: LAB) and Addus Homecare (NASDAQ: ADUS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
REPLReplimune Group
OVIDOvid Therapeutics
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

FLB Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
0
0
0
In the current month, FLB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. FLB average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

FLB Stock Forecast FAQ

What is CH:FLB’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:FLB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:FLB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Standard BioTools a Buy, Sell or Hold?
      Currently, no data Available
      What is Standard BioTools’s share price target?
      Currently, no data Available
      What do analysts say about Standard BioTools?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Standard BioTools?
      To buy shares of CH:FLB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.